Novavax’s Covid vaccine got its green light — and the stock is tumbling. Here’s why.


A link to allergic reactions in Europe overshadowed the good news about FDA approval.

Previous Corporate Counsel Awards 2022: Chris Koster oversees legal strategy for multiple acquisitions at Centene Corp.
Next Hemogenyx Pharmaceuticals plants flag in West Harlem